To the best of our knowledge, this is the first study to report on the mechanism underlying the ameliorating effects of XYS on depression from the perspective of gastrointestinal inflammation based on the TLR4/NLRP3 inflammasome signaling pathway. Here, NLRP3 is linked to depressive symptom measurement.